Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Coya Therapeutics Inc., 3 years.
Coya Therapeutics Inc.
Director
Gain Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 23, 2026 | BioAge Labs Inc. | Option exercise | +3,542 | $4.38 | $15,514 |
| Mar 1, 2026 | BioAge Labs Inc. | Option exercise | +3,542 | $4.38 | $15,514 |
| Feb 1, 2026 | BioAge Labs Inc. | Option exercise | +3,541 | $4.38 | $15,510 |
| Jan 16, 2026 | BioAge Labs Inc. | Option exercise | +3,542 | $4.38 | $15,514 |
| Jan 13, 2026 | BioAge Labs Inc. | Option exercise | +27,000 | $8.39 | $226,530 |
| Jan 13, 2026 | BioAge Labs Inc. | Open-market sale | −8,974 | $18.43 | $165,391 |
| Jan 13, 2026 | BioAge Labs Inc. | Open-market sale | −4,440 | $19.45 | $86,358 |
| Jan 13, 2026 | BioAge Labs Inc. | Open-market sale | −11,663 | $20.54 | $239,558 |
| Jan 13, 2026 | BioAge Labs Inc. | Open-market sale | −1,923 | $21.08 | $40,537 |
| Aug 18, 2025 | Coya Therapeutics Inc. | Option exercise | +17,557 | $1.09 | $19,137 |
| Jan 3, 2023 | Coya Therapeutics Inc. | Open-market purchase | +10,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.